Company | SI-BONE

Meet SI-BONE

Advancing the diagnostic understanding of the sacroiliac joint and minimally invasive surgery for certain causes of SI joint disorders.

Company

Spotlight

SI-BONE is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Published clinical studies have shown that 15% to 30% of chronic lower back pain is associated with the sacroiliac (SI) joint. In 2009, SI-BONE pioneered a proprietary minimally invasive surgical system, the iFuse Implant System®, to fuse the SI joint and treat SI joint dysfunction. Tens of thousands of patients have subsequently been treated with iFuse by thousands of trained surgeons around the world.

SI-BONE has more recently expanded its iFuse Technology® platform to include iFuse-3D™ and has cleared indications in pelvic trauma and adult spinal deformity.

SI-BONE is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (SI) joint. The iFuse Implant System® is intended for sacroiliac joint fusion including use in high and low energy fractures of the pelvic ring.

3,000+Behandelnde Chirurgen

75,000+Durchgeführte iFuse Eingriffe

100+Publikationen zu iFuse

Sie suchen nach Antworten?

Da können wir helfen. Wonach suchen Sie?